4

FORM 4 SUBMISSION

Company: KalVista Pharmaceuticals, Inc.
Filed: December 31, 2015
Period of Report: December 30, 2015
Accession Number: 0000899243-15-010542

View Document ↗ View on SEC.gov ↗